debrisoquin has been researched along with piperidines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aichele, G; Antonin, KH; Bieck, PR; Gleiter, CH; Hengen, N; Nilsson, E | 1 |
| Idle, JR; Lockhart, JD; Oates, NS; Shah, RR; Smith, RL | 2 |
| Heninger, GR; Kendler, KS; Roth, RH | 1 |
| Dahl, ML; Halldin, C; Nyberg, S | 1 |
| Bieck, PR; Feifel, N; Jedrychowski, M; Schmidt, EK | 1 |
1 trial(s) available for debrisoquin and piperidines
| Article | Year |
|---|---|
A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
Topics: Adult; Antipsychotic Agents; Debrisoquin; Genotype; Humans; Isoxazoles; Male; Piperidines; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Tomography, Emission-Computed | 1995 |
5 other study(ies) available for debrisoquin and piperidines
| Article | Year |
|---|---|
Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development.
Topics: Adult; Debrisoquin; Drug Evaluation; Female; Humans; Hydroxylation; Isoquinolines; Kinetics; Male; Phenotype; Piperidines; Polymorphism, Genetic; Serotonin | 1985 |
Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.
Topics: Adult; Aged; Alcohol Drinking; Angina Pectoris; Debrisoquin; Female; Humans; Isoquinolines; Liver Function Tests; Male; Middle Aged; Oxidation-Reduction; Perhexiline; Peripheral Nervous System Diseases; Piperidines; Smoking | 1982 |
Prediction of subclinical perhexiline neuropathy in a patient with inborn error of debrisoquine hydroxylation.
Topics: Angina Pectoris; Debrisoquin; Electromyography; Humans; Hydroxylation; Isoquinolines; Male; Middle Aged; Perhexiline; Peripheral Nervous System Diseases; Phenotype; Piperidines; Polymorphism, Genetic | 1983 |
Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
Topics: Animals; Benzimidazoles; Brain; Corpus Striatum; Debrisoquin; Domperidone; Haloperidol; Homovanillic Acid; Male; Phenylacetates; Piperidines; Rats; Receptors, Dopamine | 1981 |
Metabolism of the new MAO-A inhibitor brofaromine in poor and extensive metabolizers of debrisoquine.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Male; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Piperidines | 1993 |